Home Politics Religion Media Biz Society Tech Travel Books Intl. Autos Automobiles
                        Aviation   Pharma   About Us   Feedback   Links
BAN ON ANIMAL PROTEIN IN CATTLE FEED AGAINST MAD COW DISEASE
 

US may ban animal protein in cattle feed to safeguard against mad cow

Revision to livestock feed rule; animal protein to be banned to protect against mad cow disease in US.


BY OUR PHARMA CORRESPONDENT

20 September,2005: The U.S. Food and Drugs Administration is close to ban animal protein from cattle feed government will as a measure of expanding existing safeguard against deadly mad cow disease.

During remarks to a consumer group meeting on food safety, FDA Commissioner Lester Crawford said the FDA would issue its long-expected revisions to the so-called livestock feed rule "very quickly."

The ban could include all animal protein from cattle feed, Crawford said. The FDA's Center for Veterinary Medicine is in the final stages of preparing the new rule, which will supersede what was proposed by the agency more than a year ago.

The FDA, which oversees animal feed, said last month it was considering a broader ban on use of poultry litter, table scraps and cattle blood in feed, as well as more restrictions on use of items thought to carry the highest risk of spreading Mad Cow disease.

Always fatal, bovine spongiform encephalopathy is believed to be spread among cattle through consumption of feed that contains material from infected cattle. People can contract a human version of the Mad Cow disease by eating contaminated meat.

The major U.S. safeguard against mad cow disease is a 1997 ban on using the remains of cattle as a protein supplement in cattle feed.

Other Mad Cow disease safeguards include a prohibition against slaughtering "downer" cattle -- animals too sick to walk on their own – for human food, and a requirement for meatpackers to remove from carcasses the brains, spinal cords, nervous tissue and other parts most likely to contain the malformed proteins blamed for the disease.

Last month, the U.S. government wrapped up its investigation into the first domestic U.S. case of mad cow disease, diagnosed in a Texas animal in June. It concluded that the animal was infected before the 1997 livestock feed ban was adopted.

It was the first U.S.-born cow found with BSE and the second U.S. case overall. The earlier Mad Cow disease case was found in December 2003 in a dairy cow imported from Canada to Washington state, according to reports.

BY OUR PHARMA CORRESPONDENT

 

   Pharma Home
LATEST UPDATES

Chinese herbal products could be dangerous: UK 

Knock, knock! It's bird flu at the door

Spider anti-venom to be stocked in UAE hospital 

US may ban animal protein in cattle feed to safeguard against mad cow 

Dr Reddy's nizatidine generic gets FDA nod

Late-onset Pompe disease drug goes on trial

First biologic to treat ulcerative colitis gets US FDA okay

Diverticulitis orally dissolving pill from KV Pharma's  hits the market

Impax delisted from Nasdaq

US FDA okays Lupin's cephalexin

Hepatitis C combo therapy to get priority review in Japan

Lung cancer vaccine trials promising: Introgen

Sugar-free pill Actiq for cancer pain

39 drug firms sued over price rigging in California

Anti fungal terbinafine launched in Europe: Actavis

HIV entry blocking drug data encouraging: Progenics

Allegra generic to be launched in US

Long-acting pain drug data positive: Pain Therapeutics

New kidney cancer drug seeks EU nod

Inhaled insulin may get US FDA clearance

A vaccine against fungus is on way

Enzyme stops progression of HIV in survivors, confirms study

Aclasta found faster-acting in Paget's disease treatment

Beta blocker can start therapy in heart failure: Merck

Halobetasol generic launched in US

Anemia drug darbepoetin's late-stage studies begin: Amgen

Cholesterol generic gets marketing nod in US: Par

Aricept for severe Alzheimer’s disease too: Eisai

Bone regeneration trials begin in US:Mesoblast

New dye to detect early Alzheimer's

Breast forming gene discovered

Thyroid drug to be supplied by IVAX in US

Rituxan, cancer drug can treat rheumatoid arthritis

Yasminelle, low-dose oral contraceptive approved in the Netherlands

Fluarix, anti-flu shot by Glaxo approved

Increlex, drug to treat `abnormally short’ kids approved in US

Anti-HIV drugs prices cut: Gilead

US FDA approves Takeda’s drug combo for type 2 diabetes

Novartis’ drug for breast cancer recurrence to be given priority review in US

US puts off decision on contraceptive pill again

Shire’s ADHD drug Adderall back on list in Canada

WHO calls for emergency action to halt TB in Africa

Some of the Vioxx suits may be settled: Merck

Nasdaq delists Able on bankruptcy filing

Hospira ships ceftriaxone generics to US

Renovis stops sciatica drug studies

 

Home Politics Religion Media Biz Society Tech Travel Books Intl. Autos Automobiles
                        Aviation   Pharma   About Us   Feedback   Links

Latest updates    Contact Us - Feedback    About Us